作为尿路癌的生物标志物的β2-整合素
Marc Llort Asens1, Imran Khan1, Susanna Carola Fagerholm1
1MIBS research programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.
PloS one
|October 24, 2025
概括
贝塔2-整合素对泌尿器癌的抗瘤免疫有影响. 某些β2-整合素与更好的生存率和免疫细胞透相关,而另一些与糟糕的结果和改变的髓状细胞活性有关.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- β2-整合素是关键的免疫细胞粘附蛋白,参与抗瘤免疫.
- 它们在尿癌中的特定作用,特别是关于免疫细胞透和髓状细胞活性,尚不清楚.
- 了解β2-整合素的功能是解读复杂瘤免疫微环境的关键.
研究的目的:
- 研究各种β2-整合素及其调节剂在尿路癌中的作用.
- 为了将β2-整合素表达与患者的存活率和免疫治疗反应相关联.
- 为了分析β2-整合素对瘤骨髓状免疫场景的影响.
主要方法:
- 来自尿路癌患者的RNA表达数据的分析.
- 在beta2-整合素基因表达和患者生存数据之间的相关性分析.
- 使用EcoTyper分析来评估免疫细胞透模式.
- 研究β2-整合素表达与免疫治疗反应之间的关系.
主要成果:
- ITGAL (CD11a) 和FERMT3 (kindlin-3) 的表达与患者的存活时间正相关.
- 在ITGAL高样本中观察到CD8+ T细胞和NK细胞的透增加.
- ITGAM (CD11b),ITGAX (CD11c) 和FLNA (filamin A) 的表达与生存率差和免疫治疗反应降低相关.
- 后者基因关键调节瘤髓状免疫格局,包括巨细胞和树突细胞.
结论:
- 贝塔2-整合素表达模式可以根据他们的免疫格局来区分泌腺癌患者.
- 特定的β2-整合素 (ITGAL,FERMT3) 与有利的结果和抗瘤免疫细胞透有关.
- 其他β2-整合素 (ITGAM,ITGAX) 和调节剂 (FLNA) 与预后不佳和骨髓驱动的瘤进展有关.
- 贝塔2-整合素显示出作为生物标志物的潜力,用于预测患者对泌尿器癌治疗的反应.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.7K
04:15Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
2.3K
相关概念视频
01:10Integrins
5.2K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.2K
01:15Activation of Integrins
4.9K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.9K
01:17Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
01:25Selectins
4.1K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.1K